A retrospective analysis of more than 140,000 cat medical records from Banfield Pet Hospital clinics across the United States shows that while heartworm testing remains underused, the disease is disproportionately represented among cats presenting with cough, wheeze or vomiting—symptoms often attributed to asthma or gastrointestinal upset.
Cats with heartworm infection rarely display the classic cardiovascular signs seen in dogs. Instead, the parasite’s immature larvae and dying adult worms provoke intense inflammation in the pulmonary arteries, a condition known as heartworm‑associated respiratory disease (HARD). The resulting bronchial irritation, airway narrowing and, in some cases, acute thromboembolism can manifest as coughing, dyspnea, wheezing or, less commonly, vomiting. Because these signs overlap with far more prevalent feline disorders, veterinarians may not consider heartworm in the differential diagnosis, especially when testing is not routine.
Study Design and Data Sources
The investigation, led by Amber Whittle and colleagues and published in Frontiers in Veterinary Science (Nov 3‑4 2026), examined anonymized electronic medical records (EMRs) from over 1,000 Banfield clinics in 42 states, the District of Columbia and Puerto Rico. The records spanned a ten‑year period (2013‑2023), predating the American Heartworm Society’s (AHS) 2024 recommendation for annual heartworm screening in cats.
Inclusion required at least one of three diagnostic codes: (1) suspected feline heartworm infection, (2) any respiratory complaint (cough, asthma, dyspnea, bronchitis, wheeze), or (3) vomiting. Cats also had to have at least one documented heartworm antigen (Ag) or antibody (Ab) test to enter the final analytical dataset.
To manage the massive, multi‑table EMR system, the researchers employed a large language model (ChatGPT‑4) alongside conventional machine‑learning tools. The AI assisted in deduplicating records, extracting structured lab results, aligning test dates with clinical observations, and flagging necropsy reports for qualitative review.
Cohort Overview
- Total eligible cats (any qualifying sign): 146,111
- Cats with at least one heartworm test: 91,438 (62.6 % of eligible)
- Cats never tested despite compatible signs: 54,673 (37.4 %)
Among the tested population, 1,555 cats (1.70 %) yielded a positive result on any heartworm assay (antigen, antibody, or combined reference‑lab test).
Positivity by Clinical Presentation
Cats were grouped by the first recorded sign that prompted evaluation:
| First recorded sign | Cats tested | Positive cats | Positivity rate |
|---|---|---|---|
| Suspected heartworm (specific code) | 1,471 | 1,289 | 87.6 % |
| Respiratory signs (cough, asthma, dyspnea, etc.) | 25,280 | 109 | 0.43 % |
| Vomiting | 64,687 | 157 | 0.24 % |
| All tested cats | 91,438 | 1,555 | 1.70 % |
Although the absolute positivity is highest among cats flagged with a heartworm code, the sheer volume of respiratory and vomiting presentations means that over 17 % of all positive cases arose from cats whose initial complaint was cough, wheeze or vomiting. This underscores the hidden burden of heartworm disease among cats evaluated for common, non‑specific signs.
Demographic Risk Patterns
Sex and reproductive status
- Of the 91,438 tested cats, reproductive status was recorded for 89,350 (97.7 %).
- Intact males had the highest positivity (7.13 %).
- Intact females followed (4.89 %).
- Neutered males (1.48 %) and spayed females (1.55 %) showed markedly lower rates.
Age
- Cats aged 3–6 years exhibited the highest positivity (2.15 %).
- The 1–3 year group was close behind (1.94 %).
- Positivity declined in older age brackets, suggesting that exposure and infection often occur in early to middle adulthood.
Test Modality Performance
Cats frequently underwent multiple tests over the decade, allowing comparison of assay types:
- Antigen (Ag) tests: 144,804 total assays; 1.24 % positive.
- Antibody (Ab) tests: 136 standalone assays; 7.35 % positive.
- Combined Ag/Ab reference‑lab panels: 1,164 assays; 4.21 % positive.
The higher positivity of antibody assays reflects their ability to detect exposure to immature larvae (the stage responsible for HARD). However, antibody tests cannot confirm the presence of adult worms, while antigen tests, though specific for mature female worms, miss many infections in cats because of low worm burdens, single‑sex infections, or antigen–antibody complexing.
Concordance and Discordance Between Antigen and Antibody Results
A subset of 127 cats had both an antigen and an antibody result recorded.
Concordant results (both positive or both negative) occurred in 96 cats (75.6 %):
- 90 were double‑negative (Ag−/Ab−).
- 6 were double‑positive (Ag+/Ab+), confirming active infection.
Discordant results were seen in 31 cats (24.4 %):
- Ag+/Ab− in 28 cats (90 % of discordant cases). Most (71 %) of these were obtained on the same day, suggesting that a positive antigen can appear even when the host has not yet mounted a detectable antibody response.
- Ag−/Ab+ in 3 cats (10 %). These tests were spaced far apart (median interval ≈ 1,665 days), indicating that antibody positivity may persist long after antigen becomes undetectable, or that the initial antigen test missed an early infection.
The predominance of Ag‑positive/Ab‑negative results highlights the clinical relevance of performing both assays when heartworm disease is suspected, especially in cats with acute respiratory signs.
Necropsy Case Series
Natural‑history confirmation came from six necropsy reports identified through the AI‑driven text search. Five cats had adult Dirofilaria immitis worms or fragments in the heart or pulmonary vessels. Key observations:
- Four cats died suddenly at home, a classic presentation of fatal pulmonary thromboembolism.
- One cat presented in severe respiratory distress after a prolonged car ride and died shortly after arrival at the clinic.
- Only two of the five necropsy‑confirmed cats had ever been tested for heartworm, and both tests were antigen‑negative (one performed 1,590 days before death).
- Preventive history was poor; one indoor/outdoor cat received a single 6‑month supply of topical preventive at its first visit but the owner never refilled it despite repeated veterinary advice.
These findings illustrate the diagnostic blind spot that can exist even when owners are offered testing and prophylaxis.
Clinical Implications
The study’s data reveal three actionable messages for veterinarians and cat owners:
- Heartworm testing should be considered for any cat with unexplained cough, wheeze, dyspnea, or recurrent vomiting, regardless of the presence of classic risk factors such as outdoor access.
- Both antigen and antibody assays are needed to maximize detection. Relying on antigen alone will miss many cases of HARD, while antibody positivity alone cannot confirm active adult infection but does flag recent exposure.
- Preventive coverage remains critical. Because adulticide therapy is unsafe in cats, the only practical strategy to avoid fatal outcomes is year‑round macrocyclic lactone prophylaxis, as advocated by the AHS and reinforced by the study’s finding that most positive cats were intact and therefore more likely to roam outdoors.
Limitations
The retrospective design can only establish associations, not causation. Diagnostic coding may have misclassified some presentations, and the reliance on EMR data means that subtle clinical nuances (e.g., severity of coughing) were unavailable. The study also reflects a population that primarily accesses veterinary care through Banfield’s wellness‑plan model, which may differ from cats seen in private practices or shelters. Finally, the antibody test sample size (136 assays) was small relative to antigen testing, limiting precise estimation of antibody assay performance.
Unresolved Question
Given that 37 % of eligible cats never received heartworm testing, future prospective studies should explore barriers to testing—whether owner perception, cost, or clinician awareness—and assess whether systematic screening of cats with respiratory or gastrointestinal signs improves outcomes.